The first cancer clinical trial underway at UT Health San Antonio Multispecialty and Research Hospital is exploring an approach researchers say could change how cancer is treated.
In a recent interview with Texas Public Radio, Jessica Treviño Jones, MD, a breast medical oncologist at Mays Cancer Center shared insight to the Phase 2 study of an investigational therapy called STAR0602. The trial is testing an immunotherapy designed not only to attack cancer, but to help the immune system recognize it and continue responding over time.
The concept of a therapy building lasting immune “memory” is what sets this research apart. The goal is to move beyond treatments that only work in the moment and instead help the body keep fighting even after therapy ends.
This work is happening now inside our hospital, where discovery and patient care combine to bring promising new options closer to home for South Texans.
Explore More
- Find cancer specialists and care at UT Health San Antonio.
- Explore cancer research and cancer clinical trials.
- Read more about the Phase 2 study of STAR0602.
Read the Full Story
Hear from the researcher in the full story from Texas Public Radio.